Cosmetic Advisories

FDA Advisory No. 2017-229 || Public Health Warning Against the Use of Counterfeit Cosmetic Products (Batch 1)

FDA Advisory No. 2017-229

Public Health Warning Against the Use of Counterfeit Cosmetic Products (Batch 1)

The Food and Drug Administration (FDA) advises the public against the purchase and use of the following counterfeit cosmetic products whose particulars/details are provided in the attached annex:

 

  1. MAYBELLINE NEW YORK THE COLOSSAL GO! EXTREME 3IN1 LASHBLAST 24HR (LIPGLOSS+MASCARE+EYE LINER)
    1. MAYBELLINE NEW YORK THE COLOSSAL GO! EXTREME VOLUM MASCARA
    2. MAYBELLINE NEW YORK THE COLOSSAL GO! EXTREME EYELINER
    3. MAYBELLINE NEW YORK THE COLOSSAL GO! EXTREME LIP GLOSS
  2. MAYBELLINE NEW YORK THE COLOSSAL KAJAL WATER-BASED PEN 24H GLAM BLACK, BOLD + SMUDGE RESISTANT
  3.   L’ORÉAL PARIS SKIN NATURAL BB CREAM MIRACLE BB CREAM SKIN BEAUTIFIER
    1. L’ORÉAL PARIS SILK PORELESS WHITE PRESSED POWDER BB CAKE POWDER SILKY SMOOTH TEXTURE
  4. L’ORÉAL PARIS DERMO-EXPERTISE RE·NOURISH CLEANSING WIPES

FDA, in coordination with the Market Authorization Holder (MAH) for Maybelline New York and L’Oreal Paris, has verified that the aforementioned cosmetic products are COUNTERFEIT.

 

Counterfeit products, not having gone through the required safety assessment and the verification process of the FDA, pose potential health hazards to the consuming public since their safety and purity cannot be guaranteed. The dangers/hazards may come from ingredients that are not allowed to be part of a cosmetic product or from the contamination of heavy metals such as lead and mercury. The use of substandard and possibly adulterated cosmetic products may result to adverse reactions including but not limited to skin irritation, itchiness, anaphylactic shock and organ failure. In the case of counterfeit eye products such as mascaras and eyeliners, adverse reactions may manifest as eye redness, irritation, swelling and discharge.

 

In light of the above, the public is advised to be vigilant against buying and using the aforementioned counterfeit products. Moreover, the public is also advised to be vigilant against cosmetic products that might not be duly notified with FDA. Always check if a cosmetic product has been notified with FDA before purchasing it by making use of the embedded Search feature of the FDA website accessible at www.fda.gov.ph.

All concerned establishments are warned not to distribute the above-identified violative cosmetic products, otherwise, regulatory actions and sanctions shall be strictly pursued.

 

All Local Government Units (LGUs) and Law Enforcement Agencies (LEAs) are requested to ensure that these products are not sold or made available in their localities or areas of jurisdiction.

 

To report any suspicious and/or illegal activity involving the said products, the public may contact FDA through its online reporting facility, eReport, at www.fda.gov.ph/ereport, or e-mail us at This email address is being protected from spambots. You need JavaScript enabled to view it., or call the Center for Cosmetics Regulation and Research (CCRR) hotline (02) 857-1979 or (02) 857-1984.

 

For more information and inquiries regarding L’Oreal Paris and Maybelline New York products, consumers may contact the MAH through any of the following contact information:

 

Product Brand

Contact Information

L’Oreal Paris

Email:

This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Hotline No.:

(02) 672-7200

 

Facebook Account:

https://www.facebook.com/LOrealParisPhilippines/

 

 

Maybelline New York

Email:

This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Hotline No.:

(02) 672-7227

 

Facebook Account:

https://www.facebook.com/maybellinephilippines/

 

 

Dissemination of the information to all concerned is requested

 

Share Us on

Submit to FacebookSubmit to Google PlusSubmit to Twitter